Bacteriophage Nanostructures for Targeted Bacterial Lysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The rise of antibiotic-resistant bacteria strains poses a significant challenge in treating infections, as traditional antibiotic therapies are less effective, and there is a need for innovative approaches to combat multidrug-resistant and pandrug-resistant bacteria.
Innovation Solution
A nanostructure comprising antimicrobial components, such as antibiotics, antimicrobial peptides, or secondary metabolites, loaded into a carrier component, along with bacteriophage receptor binding proteins or peptide sequences, designed to target and lyse pathogenic bacteria by directly interacting with bacterial cells, enhancing the efficacy of antimicrobial agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional antibiotics are used to treat bacterial infections, then treatment effectiveness is maintained against susceptible bacteria, but antibiotic resistance develops leading to treatment failure against resistant strains
Solution Approach 1:
The patent segments the antimicrobial system into multiple functional components: a core portion containing antimicrobial agents (antibiotics, antimicrobial peptides, or secondary metabolites) and a surface portion displaying bacteriophage receptor binding proteins. This segmentation allows the nanoparticle to simultaneously provide broad antimicrobial activity from the core while achieving specific targeted delivery through the phage binding proteins on the surface, thereby maintaining treatment effectiveness against resistant strains without contributing to resistance development.
Solution Approach 2:
The patent uses bacteriophage receptor binding proteins as intermediaries to mediate the interaction between the nanoparticle and bacterial cells. These proteins, displayed on the nanoparticle surface, specifically bind to receptors on target bacteria, enabling targeted delivery of the antimicrobial core. This intermediary mechanism allows the system to overcome antibiotic resistance by delivering antimicrobial agents directly to resistant bacteria through a different mechanism than traditional antibiotics, which resist through metabolic pathways.
2Adaptability or versatility
If conventional antibiotic therapy is applied, then broad-spectrum coverage is achieved, but selective targeting of resistant bacteria is lost
Solution Approach 1:
The nanoparticle system combines multiple functions into a single platform: it provides broad-spectrum antimicrobial activity through the core portion that can accommodate different classes of antimicrobial agents (antibiotics, peptides, metabolites), while simultaneously enabling selective targeting through the bacteriophage receptor binding proteins on the surface. This multi-functionality allows the system to maintain adaptability against various bacterial strains while achieving precise targeting of resistant bacteria through phage-specific receptor recognition.
Solution Approach 2:
The patent creates a composite nanoparticle structure combining inorganic or organic core materials containing antimicrobial agents with biological surface components (bacteriophage receptor binding proteins). This composite structure integrates the broad-spectrum antimicrobial properties of diverse antimicrobial agents with the high specificity of phage-receptor interactions, achieving both universal coverage and precise targeting in a single therapeutic agent.
3Ease of operation
If antibiotics are administered systemically, then widespread distribution occurs, but off-target effects and resistance spread increase
Solution Approach 1:
The nanoparticle system applies local quality by concentrating antimicrobial activity specifically at the target bacterial site rather than distributing it systemically. The bacteriophage receptor binding proteins on the nanoparticle surface provide localized recognition and binding to specific bacterial receptors, ensuring that the antimicrobial core is delivered only to target bacteria. This localized action eliminates off-target effects on normal flora and prevents the spread of resistance genes through non-target organisms, while still achieving effective treatment through focused delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanostructure effectively targets and lyses resistant bacteria, offering a synergistic effect with antimicrobial agents, potentially reducing resistance development and improving treatment outcomes for infections caused by resistant pathogens.
Implementation Method 1
one or more bacteriophage receptor binding proteins and/or one or more peptide sequences of the said bacteriophage receptor binding protein, attached on the said core portion
Implementation Method 2
The nanostructure effectively targets and lyses resistant bacteria, offering a synergistic effect with antimicrobial agents
Data Source
AI summary
A nanostructure for lysis of pathogenic bacteria in mammals is provided. The nanostructure includes one or more antimicrobial components loaded into one or more carrier components forming a core portion. The nanostructure also includes one or more bacteriophage receptor binding proteins and/or one or more peptide sequences of the one or more bacteriophage receptor binding proteins attached on the core portion. A method for obtaining such a nanostructure is also provided.